·|¡@¡@°T Á`´Á¼Æ¡G²Ä887´Á 2017¦~²Ä031´Á(106.07.31~106.08.04)~CAPA·|°T¤U¸ü~ ¬d Åç µn °O ¬Û Ãö °T ®§ ƒÜ ¥» ¶g °T ®§ 1. ²Ä¤C¤Q¤C©¡ÃĨƽ׾ÂÁ¿®y¡u°ê¤º¥~Á{§É¸ÕÅçº[²ÓMªvÀøªk³W³Ì·s¶i®i¤§¬ã°Q·|¡vq©ó106¦~7¤ë31¤é(¤@)¤U¤È14:00-17:00¡A°²¤TxÁ`Âå°|²Ä¤@ºtÁ¿ÆU(¥x¥_¥«¤º´ò°Ï¦¨¥\¸ô¤G¬q325¸¹B1)¥l¶}¡C 2. ½Ã¥ÍºÖ§Q³¡q©ó106¦~7¤ë31¤é(¤@)¤U¤È14:30¡A°²½ÃºÖ³¡¹Ãĸp©¾§µ¤j¼ÓC201·|ij«Ç¥l¶}¡iÃĨƪk³¡¤À±ø¤å×¥¿¯ó®×¡u²£·~·¾³q¨ó½Õ·|ij¡v¡j¡A¥»¤½·|¥Ñ¼ï¨q¶³±`°È²z¨Æ¤Î±i¤¯»¨°Æ¥D¥ô©eû¥Nªí°Ñ¥[¡C ƒÜ ªñ ´Á °T ®§ 1. °]¹Îªk¤HÂåÃÄ«~¬dÅ礤¤ßÁ|¿ì¦³Ãö¡u106¦~«×°·±d¹«~¬dÅçµn°Oªk³Wº[±`¨£¯Ê¥¢«Å¾É·¾³q»¡©ú·|I I¡v(¥x¥_³õ¤Î¥x¤¤³õ)¡C 2. °]¹Îªk¤HÃÄ®`±ÏÀÙ°òª÷·|¯÷q©ó106¦~8¤ë5¤é¡]¤»¡^Á|¦æ¡uÃÄ«~¡BÂåÀø¾¹§÷»P°·±d¹«~¦w¥þºÊµø¬ã°Q·|º[106¦~8¤ëÁ{§ÉÃľǷ|«n°ÏÂù¤ë·|¡v¡AÅwªï·|û¿ãÅD³ø¦W°Ñ¥[¡C 3. °]¹Îªk¤HÂåÃÄ«~¬dÅ礤¤ß±N©ó106¦~8¤ë10¤é¡]¬P´Á¥|¡^15¡G00¡ã17¡G00¡A°²½Ã¥ÍºÖ§Q³¡¹«~ÃĪ«ºÞ²z¸p©¾§µ¿ì¤½«ÇC201·|ij«Ç(¥x¥_¥«©¾§µªF¸ô¤»¬q467¸¹¦a¤U2¼Ó)¡AÁ|¿ì±MÃDºtÁ¿¡G¡u¬ü°ê21¥@¬öÂåÀøªk®×¤§²{ªp»P¬D¾Ô¡v¡AÅwªï·|û¿ãÅD³ø¦W°Ñ¥[¡C¥»¤½·|¥Ñ¼ï¨q¶³±`°È²z¨Æ¤Î¾Gµq¤¤¥D¥ô©eû¥Nªí¥X®u¡C
4. Ãö¶Tºô¸ôªÑ¥÷¦³¤½¥q©Ó¿ì½Ã¥ÍºÖ§Q³¡¹«~ÃĪ«ºÞ²z¸p¡u¹«~ÃĪ«·~ªÌµn¿ý¥¥x¡v¤Î¡uÃÄ«~°l·¹©Î°lÂܹq¤l¥Ó³ø¨t²Î¡v¬ÛÃö»¡©ú·|¤Î±Ð¨|°V½m¡AÅwªï·|û¿ãÅD³ø¦W°Ñ¥[¡C 5. ªÀ¹Îªk¤H¤¤µØ¥Á°ê¾Ç¦WÃĨó·|ÀÀ©ó106¦~8¤ë17¤é(¥|)09:30-16:30¡A°²¶°«ä¥_¬ì¤j·|ij¤¤¤ß¦ãº¸ªkÅ¥(¥x¥_¥«©¾§µªF¸ô¤T¬q197¸¹®Ç »õ¥ú¤j¼Ó3¼Ó)Á|¿ì¡u106¦~ÃÄ«~GDP¨t¦C½Òµ{¬ã°Q·|-¤p«¬³c½æ·~ÃÄ°Ó¦p¦ó«Ø¥ßGDP¤§§@·~³õ©Ò¡v¡AÅwªï·|û¿ãÅD³ø¦W°Ñ¥[¡C 6. °]¹Îªk¤HÂåÃÄ«~¬dÅ礤¤ßq©ó106¦~8¤ë21¤é¥l¶}¡u106¦~²Ä3¦¸²£©x¾Ç·¾³q·|ij¡v¡A¥»¤½·|¥Ñ¼ï¨q¶³±`°È²z¨Æ¤Î¾Gµq¤¤¥D¥ô©eû¥Nªí¥X®u¡C 7. °]¹Îªk¤H¥xÆW¹q¤lÀËÅ礤¤ßÁ|¿ì¡u°ê²£Âå§÷»s³y·~ªÌ¤§ÂåÀø¾¹§÷Àu¨}»s³y³W½d½×¾Â(II)-- ÂåÀø¾¹§÷·Àµß»sµ{»P½T®Ä¹ê°È»¡©ú¡v¡AÅwªï·|û¿ãÅD³ø¦W°Ñ¥[¡C 8. ªÀ¹Îªk¤H¤¤µØ¥Á°ê¾Ç¦WÃĨó·|±N©ó8¤ë30¤é¤Î9¤ë1¤éÁ|¿ì¥DÃD½×¾Â(¤G)¡Ð©e¥~ÜÀx¤Î¹B¿éºÞ²z(¤T)¡ÐÜÀx¤Î¹B¿é§@·~ºÞ²z¡AÅwªï·|û¿ãÅD³ø¦W°Ñ¥[¡C Âå Àø ¬F µ¦ »P ÃÄ »ù ¬Û Ãö °T ®§ ƒÜ ªñ ´Á °T ®§ 1. CAPA¡®TPADAÂåÀø¬Fµ¦»PÃÄ»ù©eû·|Áp®u·|ij©ó106¦~8¤ë8¤é(¤G)¤¤¤È12:00-14:00¡A°²¨â·|¦X¸p¿ì¤½·|ij«Ç¥l¶}¡C Âå Àø °| ©Ò ¬Û Ãö °T ®§ ƒÜ ªñ ´Á °T ®§ 1. CAPA¡®TPADA ÂåÀø°|©Òµo®i©eû·|Áp®u·|ij©ó106¦~8¤ë9¤é(¤T)¤¤¤È12:00-14:00¡A°²¨â·|¦X¸p¿ì¤½·|ij«Ç¥l¶}¡C
2. ¤½¥¥æ©ö©eû·|q©ó106¦~8¤ë11¤é(¬P´Á¤)¤U¤È°²»O¥_¥«»O¤jÂå°|°ê»Ú·|ij¤¤¤ß(402AB«Ç)Á|¿ì¡uÃÄ«~²£·~Ävª§»Pµo®i¡v«Å¶Ç»¡©ú·|¡AÅwªï·|û¿ãÅD³ø¦W°Ñ¥[¡C
·| °È µo ®i ¬Û Ãö °T ®§
ƒÜ ¥» ¶g °T ®§
1. CAPA ·|°Èµo®i©eû·|·|ij©ó106¦~8¤ë1¤é(¤G)¤¤¤È12:00-14:00¡A°²¨â·|¦X¸p¿ì¤½·|ij«Ç¥l¶}¡C
°T ®§ Âà ª¾ ¡¯¤½·|¦¬¤å ½Ã¥ÍºÖ§Q³¡ µo¤å¤é´Á/¤å¸¹¡G106.8.1/½Ã±Â¹¦r²Ä1061407221¸¹¨ç ¤½·|¦¬¤å106566¸¹(8¤ë) ¥D¦®¡G¦³Ãödasabuvir¡Bombitasvir/paritaprevir/ritonavir¦¨¤ÀÃÄ«~¤§ÃÄ«~¦w¥þ¸ê°T¡A½ÐÂા©ÒÄÝ·|û¡A½Ð¬d·Ó¡C ¡°¤½¨ç¤U¸ü µo¤å¤é´Á/¤å¸¹¡G106.8.2/½Ã±Â¹¦r²Ä1061405758¸¹¨ç ¤½·|¦¬¤å1065570¸¹(8¤ë) ¥D¦®¡GÀË°e½ÃºÖ³¡¡u¤½§i§tcodeine¦¨¤ÀÃÄ«~¥Î©ó¨àµ£·P«_©M«y¹Â¤§Á{§É®Ä¯q»P·ÀI¦Aµû¦ôµ²ªG¬ÛÃö¨Æ©y¡v¤½§i¼v¥»¦U¤A¥÷¡A½Ð¬d·Ó¡C ¡°¤½¨ç¤U¸ü µo¤å¤é´Á/¤å¸¹¡G106.8.3/½Ã±Â¹¦r²Ä1061104440¸¹¨ç ¤½·|¦¬¤å106578¸¹(8¤ë) ¥D¦®¡G¡u¦èÃÄÃÄ«~Àu¨}»s³y³W½d¡]²Ä¤@³¡¡^¡v³¡¤À³W©w×¥¿¯ó®×¡A·~¸g¥»³¡©ó106¦~8¤ë3¤é¥H½Ã±Â¹¦r²Ä1061104225¸¹¤½§i¹w§i¡A½Ð¬d·Ó¡C ¡°¤½¨ç¤U¸ü µo¤å¤é´Á/¤å¸¹¡G106.8.4/½Ã±Â¹¦r²Ä1061302002¸¹¨ç ¤½·|¦¬¤å106579¸¹(8¤ë) ¥D¦®¡G¡u¿é¤J¹«~¨t²Î©Ê¬d®Ö¹ê¬I¿ìªk¡v²Ä¥|±ø¡B²Ä¤±ø¡B²Ä¤K±ø¤Î²Ä¤T±øªþªí¡A·~¸g¥»³¡©ó¤¤µØ¥Á°ê106¦~8¤ë4¤é¥H½Ã±Â¹¦r²Ä1061301998¸¹¥O×¥¿µo¥¬¡A½Ð¬d·Ó¡C ¡°¤½¨ç¤U¸ü¡Bªþ¥ó1¡Bªþ¥ó2¡Bªþ¥ó3 ½Ã¥ÍºÖ§Q³¡¹«~ÃĪ«ºÞ²z¸p µo¤å¤é´Á/¤å¸¹¡G106.7.31/ FDAÃĦr²Ä1061407317¸¹ ®Ñ¨ç ¤½·|¦¬¤å106565¸¹(7¤ë) ¥D¦®¡G¡uMethylprednisolone¦¨¤Àª`®g¾¯ÃÄ«~¦w¥þ¸ê°T·ÀI·¾³qªí¡v·~¤wµo¥¬©ó¥»¸pºô¯¸¡A½Ð¬d·Ó¨ÃÂા©ÒÄÝ·|û¡C ¡°¤½¨ç¤U¸ü¡Bªþ¥ó µo¤å¤é´Á/¤å¸¹¡G106.8.1/ FDA·¦r²Ä1061104716¸¹¨ç ¤½·|¦¬¤å106576¸¹(8¤ë) ¥D¦®¡G¦³Ãö¦L«×ì®ÆÃļt¡uCONCORD BIOTECH LIMITED¡v(¼t§}¡G1482-1486, Trasad Road, Dholka, India-382 225 Ahmedabad, Gujarat)¸g°ê»Ú³q³ø¹H¤ÏGMP¤A®×¡A¸Ô¦p»¡©ú¬q¡A½ÐÂા©ÒÄÝ·|ûª¾·Ó¡C ¡°¤½¨ç¤U¸ü µo¤å¤é´Á/¤å¸¹¡G106.8.1/ FDA·¦r²Ä1061104713¸¹¨ç ¤½·|¦¬¤å106577¸¹(8¤ë) ¥D¦®¡G¦³Ãö¤¤°êì®ÆÃļt¡uChongqing Succeway Pharmaceutical Co. Ltd.¡v(¼t§}¡G531 Tonghe Avenue, Tongliang County, Jinlong Industrial District, Chongqing, Sichuan, 402566, China)¸g°ê»Ú³q³ø¹H¤ÏGMP¤A®×¡A¸Ô¦p»¡©ú¬q¡A½ÐÂા©ÒÄÝ·|ûª¾·Ó¡C ¡°¤½¨ç¤U¸ü ½Ã¥ÍºÖ§Q³¡¤¤¥¡°·±d«OÀI¸p µo¤å¤é´Á/¤å¸¹¡G106.7.31/°·«O¼f¦r²Ä1060050245¸¹ ¤½§i ¤½·|¦¬¤å106567¸¹(7¤ë) ¥D¦®¡G¤½§i¼È¤©¤ä¥I§tbimatoprost¦¨¤ÀÃÄ«~LUMIGAN PF Eye Drops¦@1«~¶µ¡C ¡°¤½¨ç¤U¸ü µo¤å¤é´Á/¤å¸¹¡G106.8.2 /°·«O¼f¦r²Ä1060060253¸¹ ¤½§i ¤½·|¦¬¤å106573¸¹(8¤ë) ¥D¦®¡G¤½§i¼È¤©¤ä¥I§tbrinzolamide/brimonidine¦¨¤ÀÃÄ«~SIMBRINZA* 10mg/ml + 2mg/ml eye drops, suspension¦@1«~¶µ¡C ¡°¤½¨ç¤U¸ü¡Bªþ¥ó µo¤å¤é´Á/¤å¸¹¡G106.8.2 /°·«O¼f¦r²Ä1060060439¸¹ ¤½§i ¤½·|¦¬¤å106574¸¹(8¤ë) ¥D¦®¡G¤½§i¼È¤©¤ä¥I§tnebivolol¦¨¤ÀÃÄ«~Nebilet Tablets 5mg¡C ¡°¤½¨ç¤U¸ü¡Bªþ¥ó µo¤å¤é´Á/¤å¸¹¡G106.8.2 /°·«O¼f¦r²Ä1060060529¸¹ ¤½§i ¤½·|¦¬¤å106575¸¹(8¤ë) ¥D¦®¡G¤½§i¼È¤©¤ä¥I§tbuprenorphine¦¨¤ÀÃÄ«~Transtec transdermal patch 35£gg/hr¤Î52.5£gg/hr¦@2«~¶µ¡C ¡°¤½¨ç¤U¸ü¡Bªþ¥ó µo¤å¤é´Á/¤å¸¹¡G106.8.3 /°·«O¼f¦r²Ä1060060955¸¹ ¤½§i ¤½·|¦¬¤å106580¸¹(8¤ë) ¥D¦®¡G¤½§i¼È¤©¤ä¥I§tpotassium gluconate¦¨¤ÀÃÄ«~K-Glu Oral Solution¦@1«~¶µ¡C ¡°¤½¨ç¤U¸ü¡Bªþ¥ó |